On April 20, 2022 EVERSANA reported at Pharma Partnering Summit 2022, 12-13 May, 2022 (Press release, EVERSANA, APR 20, 2022, View Source [SID1234612579]). Pharma Partnering Summit 2022 is one of the most prestigious physical and virtual events of 2022 for life sciences professionals.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The summit brings together senior executives from different parts of the world, focused on licensing, R&D collaborations, commercialization & distribution deals, fundraising, investing, digital health alliances, M&A, going public as well as broader partnering opportunities.

Join EVERSANA’s Rohit Sood, Executive Vice President, EVERSANA COMPLETE Commercialization on 13th May at 10:00 to hear him speak on "Next Generation Commercialization Models."

As pharma continues to evolve, commercialization models must also evolve. Over the last 10 years, the number of first-time launchers has tripled. However, compared to an experienced launcher, first-time launchers meet their forecast only 63% of the time.

Until recently, manufacturers considered three options to commercialize assets: sell, out-license the product or build the infrastructure to organically commercialize. An unpredictable landscape, coupled with inevitable industry pressures, is forcing manufacturers to seek a new option ­– outsourced commercialization – a more complete commercialization approach to minimize risk, allow for commercialization agility and retain greater asset value.